TrialRespiratory research2020

Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study.

Dave Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.